Okc Firm Seeking To Boost Effectiveness Of Antibiotics Receives Investment

FROM STAFF REPORTSi2E Inc. and Accele Venture Partners recently closed a $600,000 follow-on investment in Synereca Pharmaceuticals, a portfolio company of Accele Biopharma, an Oklahoma City-based biotechnology accelerator. With the most recent investment, Synereca has now received $2.5 million in funding to support its development of compounds that address the growing problem of bacterial resistance to current antibiotics. Synereca’s lead program is designed to restore or increase the effectiveness of existing antibiotics that have been compromised by drug-resistant bacteria.

BING NEWS:
  • Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics
    The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May 14-15, 2024, at Plaisterers’ ...
    03/11/2024 - 5:41 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News